Preparation of specific anti-Helicobacter pylori yolk antibodies and their antibacterial effects

Wang, B; Yang, J; Cao, S; Wang, H; Pan, X; Zhu, J; Zhou, Y; Gao, L; Li, W; Li, M

HERO ID

2821380

Reference Type

Journal Article

Year

2014

Language

English

PMID

25400721

HERO ID 2821380
In Press No
Year 2014
Title Preparation of specific anti-Helicobacter pylori yolk antibodies and their antibacterial effects
Authors Wang, B; Yang, J; Cao, S; Wang, H; Pan, X; Zhu, J; Zhou, Y; Gao, L; Li, W; Li, M
Journal International Journal of Clinical and Experimental Pathology
Volume 7
Issue 10
Page Numbers 6430-6437
Abstract <strong>OBJECTIVE: </strong>To study immunization procedures and preparation methods of specific IgY antibodies (IgY-Hp, IgY-IB) produced by hens immunized with Helicobacter pylori (Hp) bacterial antigen and recombinant Hp specific antigen IB, detect the inhibition effects on Hp growth and Hp urease activity, and study the effects of oral administration for treating Hp infection.<br /><br /><strong>METHODS: </strong>By using recombinant cholera toxin subunit B (rCTB) as an adjuvant, hens received intramuscular injection immunization for continuous 7 times at an interval of 14 days. Then, the eggs were collected; IgY was purified.<br /><br /><strong>RESULTS: </strong>On day 49 after hens were immunized, levels of two antibodies all reached 1:12800; after they were purified by Ammonium sulfate precipitation, their purity was over 80%. IgY-Hp could inhibit Hp growth and inhibit Hp urease activity; although in vitro, IgY-IB could not inhibit Hp growth but could inhibit Hp urease activity. The experiments in vivo found that when IgY-Hp or IgY-IB with sucralfate dual oral therapy was used to treat Hp infected mouse model, the cure rate all could reach 83.3%.<br /><br /><strong>CONCLUSION: </strong>According to immunization procedure, high titer specific IgY antibody (1:12800) can be obtained in 49 days and its titer remains stable. Oral administration of the specific IgY antibodies in Hp infected mice can reach a cure rate of 83.3%, and the antibodies are expected to become new drugs and therapeutic methods of targeted therapy against Hp infection.
Pmid 25400721
Wosid WOS:000345135900002
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English
Keyword Helicobacter pylori; specific IgY; antibacterial effect